How new blood test could reveal cancer long before symptoms appear

Scientists at Johns Hopkins University in the US have developed a new blood test that can detect signs of cancer up to three years before symptoms appear. When cancer is present, tumours release small fragments of genetic material into the bloodstream. Researchers found that these fragments can be identified in blood samples long before symptoms emerge. This could allow doctors to detect cancer much earlier than current screening methods, improving the chances of timely treatment read more
This could let doctors find cancer much earlier than current screening methods. Pixabay/Representational Image
Has a new way to detect cancer early been found?
Scientists at Johns Hopkins University in the US have created a new blood test that can pick up signs of cancer up to three years before any symptoms appear.
Why is this important?
This could let doctors find cancer much earlier than current screening methods, giving people a better chance of getting treated in time.
ALSO READ | British tourist dies after being 'scratched' by a pup in Morocco: How common are rabies deaths today?
STORY CONTINUES BELOW THIS AD
The study was published in Cancer Discovery and carried out by teams from different Johns Hopkins centres. It was partly supported by the US National Institutes of Health.
So, what is this new test? And what did the researchers discover from the study?
Let's take a look:
What the researchers found
The study showed that small traces of cancer can be found in a person's blood as early as three years before they are formally diagnosed.
This raises the possibility that doctors could one day spot cancer much sooner, when it is easier to treat or even cure.
When someone has cancer, tumours release tiny fragments of genetic material into the bloodstream. The researchers found that this material can be detected in blood samples well before any symptoms show up.
The study was carried out by teams from different Johns Hopkins centres. Pixabay/Representational Image
Dr Yuxuan Wang, one of the study's authors, said, 'We were surprised to find cancer signals in the blood so early. Finding cancer three years earlier gives us a chance to treat it before it spreads.'
To conduct the research, scientists used plasma samples from a major Atherosclerosis Risk in Communities (ARIC) study, which looks at risk factors linked to heart attacks, strokes, heart failure and other heart-related conditions, according to a press release.
They examined blood from 26 people who were diagnosed with cancer within six months of giving the sample, and compared it with samples from 26 people who were not diagnosed with cancer.
STORY CONTINUES BELOW THIS AD
Out of the 52 people, eight tested positive using a multi-cancer early detection (MCED) lab test and were later diagnosed with cancer within four months of their blood being drawn.
Notably, MCED tests are an experimental method of screening that checks for signs of several types of cancer at the same time. According to the American Cancer Society, these tests can look for pieces of DNA, RNA or proteins from abnormal cells.
In six of the eight cancer cases, the researchers went back to check earlier blood samples, taken more than three years before diagnosis. In four of those cases, cancer markers were already present.
What do the results mean?
Dr Bert Vogelstein, senior author and professor of oncology at Johns Hopkins, said, 'This study shows the promise of MCED tests in detecting cancers very early, and sets the benchmark sensitivities required for their success.'
Dr Nickolas Papadopoulos, also a senior author and professor of oncology, added, 'Detecting cancers years before their clinical diagnosis could help provide management with a more favourable outcome. Of course, we need to determine the appropriate clinical follow-up after a positive test for such cancers.'
At present, no MCED test has received full approval from the US Food and Drug Administration (FDA) for general use. However, some are available commercially under more flexible rules as Laboratory Developed Tests.
STORY CONTINUES BELOW THIS AD
MCED tests are an experimental method of screening that checks for signs of several types of cancer at the same time. Pixabay/Representational Image
Experts say MCED tests are not meant to replace current screening methods but could become useful tools for detecting cancers earlier, particularly those like colon cancer, which are often diagnosed at later stages.
Of the eight participants whose cancers were picked up by the MCED test months before diagnosis, five later died from the disease.
According to The New York Post, excluding non-melanoma skin cancers, more than two million new cancer cases are expected in the US in 2025, with over 618,000 people projected to die from the illness.
That means nearly 1,700 deaths every day.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Indian Express

12 minutes ago

• Indian Express

Ahmedabad flight crash: DNA of 223 victims matched, 204 bodies handed over to families

By 12 pm on June 20, almost exactly eight days after the fatal crash of Air India flight AI 171, officials at Ahmedabad Civil Hospital said that a total of 223 DNA samples of victims had been identified, while 204 bodies had been handed over to their families. Medical Superintendent Dr Rakesh Joshi said, 'DNA samples of 223 deceased have been matched in the Ahmedabad plane crash on June 20 as of 11:50 am. Relatives of 220 victims have been contacted, out of which 204 families have been handed over the mortal remains, including 2 victims who died during treatment.' In a statement, Dr Joshi said that 168 of the 223 identified deceased were Indian citizens, 7 were Portuguese, 36 were British citizens, one was Canadian and 11 were non-passengers. He said that 15 mortal remains were taken to the families' residences by air, while 189 mortal remains were transported to their residences by road.

Time of India

2 hours ago

• Time of India

India emerging as major science and tech force, says UK minister at London innovation forum

The UK must harness scientific and academic relationships with India as it becomes an increasingly powerful player in the science and technology space, Britain's minister for science, research and innovation has said. During a session on 'Unlocking UK-India Collaboration for a New Era of Innovation' at India Global Forum's Future Frontiers Forum at the Science Museum in London on Thursday, Lord Patrick Vallance called for greater mobility of high-skilled professionals through the Global Talent Visa and the need to tap into complementary skills across all sectors. The minister revealed the UK government's much-anticipated Industrial Strategy would be released in a few weeks, forming the blueprint for focus areas for such a partnership with India. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like The Top 25 Most Beautiful Women In The World Articles Vally Undo "There is already a strong relationship between India and the UK, and I think it's growing," said Vallance. "But government-to-government relationships on science aren't actually what drives everything. It has to be a scientist and a scientist as well. There are important academic links. I'd like to see more of that as India becomes an increasingly powerful player in the science and tech space," he said. Live Events The forum was addressed by Commerce and Industry Minister Piyush Goyal earlier on the sector-wide benefits of the Free Trade Agreement (FTA) struck between the two countries, as it "adds value to science and technology and innovation". "A Free Trade Agreement demonstrates to the world that the two countries are friends, allies, and plan to work together closely; they trust each other," said Goyal. Vallance concurred and highlighted: "India has its focus areas, we have ours, now we need to create opportunities across those sectors." Lord Ara Darzi, the British surgeon behind a seminal review of the National Health Service (NHS) and much-needed areas of reform, hailed India's "transformative health solutions" as the "intellectual and production power" the UK must collaborate with. The forum also included a 'Pitchers and Punters' curated showcase of Indian start-ups pitching to a jury of international investors. Among the standout companies were Zypp Electric, Lina Energy, Steamology Motion Ltd and Electric Miles - with Zypp Electric winning this year's Clean Tech Award presented by British renewable energy group Octopus Energy.

New Indian Express

4 hours ago

• New Indian Express

Ahmedabad plane crash: 223 DNA matches confirmed, 204 bodies handed over to families

AHMEDABAD: DNA samples of 223 victims of the Air India plane crash have been successfully matched, and 204 bodies have been handed over to families as of 11:50 am on June 20, according to Civil Hospital Superintendent Dr Rakesh Joshi. The Civil Hospital authorities have intensified the efforts to identify and return the remaining bodies. Meanwhile, two patients under treatment at the Civil Hospital succumbed to their injuries. Their bodies have been handed over to their families, bringing the total count of bodies handed over to 204 from the Civil Hospital alone. Breaking down the identification further, Dr Joshi confirmed that the 223 matched victims comprise 168 Indian nationals, 7 Portuguese, 36 British citizens, 1 Canadian, and 11 non-passengers - local residents who were tragically caught in the crash zone.